To explore whether vvDD-IL-23 could induce an antitumor effect in late-stage tumor models, B6 mice were i.p. injected with MC38-luc or ID8-luc and these tumor-bearing mice were treated 9 days after tumor cell inoculation. The gene discussed is IL23A; the disease is neoplasm.